SurvivorNet Staff

Pfizer Oncology Leader Says The Company Wants to Continue Ongoing Efforts to Increasing Access to Screening and Quality Information Through Patient Education

Exciting Progress for Difficult-to-Treat Advanced Melanoma — What to Know About Biologic Drug Brenetafusp

Community Engagement & Resources are Key to ‘Closing the Gap’ on Racial Disparities in Cancer Care

Fighting For Multiple Myeloma Patients in Desperate Need: The Commitment From Johnson & Johnson’s Blood Cancer Leader

Give Patients “Authentic Hope”– The Mission For Drugmaker BeiGene’s Commercial Leader Josh Neiman

Pfizer’s Global Oncology Leader Suneet Varma Says Patient Education For Earlier Screening & Disease Identification Is a Major Part of His Strategy

Johnson & Johnson Blood Cancer Leader Brewer Lays Out Strategy To Break the Cycle and Improve Diversity In Clinical Trials

How to Reduce Cancer Mortality By Dramatic 20%: ASCO Leader Says Focus Should Be on Improving Access to Existing Standard of Care & Prevention

Head of Oncology at Pharma Giant AstraZeneca Leader Says Closing The Education & Care Gap For Community Patients And Doctors Is Crucial

Creating Hope & Increasing Access To Cancer Treatment, The $43 Billion Bet — A View From The Top At Pfizer

Patient Education is Key — Head of Hematology at Johnson & Johnson On Getting Multiple Myeloma Patients Access to Good Information & Care

New Immunotherapy Approvals Provide Hope for Women With Advanced Endometrial Cancer: What to Know